Collectively, these data support the hypothesis that oral-derived microbiota can serve as primary mucin degrading organisms, in turn liberating metabolites that stimulate the growth of P. aeruginosa and other CF lung pathogens. Here, MUC5AC is linked to cystic fibrosis.